EMA — authorised 27 July 2006
- Application: EMEA/H/C/000682
- Marketing authorisation holder: CNX Therapeutics Ireland Limited
- Local brand name: Savene
- Indication: Savene is indicated for the treatment of anthracycline extravasation.
- Status: approved
🇪🇺 Zinecard in European Union
EMA authorised Zinecard on 27 July 2006
Marketing authorisation
Other Cardiovascular approved in European Union
Frequently asked questions
Is Zinecard approved in European Union?
Yes. EMA authorised it on 27 July 2006.
Who is the marketing authorisation holder for Zinecard in European Union?
CNX Therapeutics Ireland Limited holds the EU marketing authorisation.